• Red Blood Cell Lysis Buffer: Reliable Workflows

  2026-08-28

  This scenario-based guide explains how Red Blood Cell Lysis Buffer, SKU K1169, can improve mammalian blood sample preparation for flow cytometry, nucleic acid extraction, protein analysis, and cell-based assays. It connects formulation, optimization, controls, and product-selection decisions to practical laboratory reproducibility.

• BHPF, GPER1 Binding, and Neuroblastoma Apoptosis

  2026-08-27

  The 2024 Environmental Science & Technology study identifies fluorene-9-bisphenol (BHPF) as a suspected GPER inhibitor rather than an activating ligand. By combining molecular dynamics, receptor-residue validation, calcium signaling, cytotoxicity, and gene-expression assays, the authors connect direct receptor recognition with altered responses in human neuroblastoma cells.

• Biotin-16-UTP: Mapping RNA–Protein Causality

  2026-08-27

  Biotin-16-UTP enables mechanistic RNA labeling for detection, purification, and RNA–protein interaction studies. This guide translates evidence from LINC02870 research into practical assay-design decisions while emphasizing controls, labeling density, and interpretation limits.

• TRPV1 and TRPA1 Control TSLP in Nasal Epithelium

  2026-08-26

  The reference study identifies a Ca2+/NFAT pathway through which TRPV1 and TRPA1 activation increases TSLP production in nasal epithelial cells. Its use of pharmacological inhibition, siRNA, calcium chelation, and NFAT localization connects channel activity with epithelial inflammatory signaling and offers a framework for interpreting upper-airway ion-channel assays.

• Substance P: Biology and Workflow Benchmarks

  2026-08-26

  Substance P is an undecapeptide tachykinin neuropeptide and experimental neurokinin-1 receptor agonist used in pain transmission research, neuroinflammation, and CNS signaling studies. Product data identify B6620 as a high-purity, water-soluble lyophilized peptide that requires desiccated frozen storage and prompt use after reconstitution.

• GTP Solution (100 mM): From IVT to Assay Quality

  2026-08-25

  Explore how GTP Solution supports reproducible in vitro transcription, RNA quality control, and downstream mRNA-LNP research. This evidence-centered guide connects nucleotide handling with assay interpretation in localized bladder cancer studies.

• Polygodial for TRPA1 Channel Assays

  2026-08-25

  Polygodial provides a practical chemical trigger for connecting TRPA1 activation with calcium influx, NFAT signaling, and inflammatory readouts. This workflow shows how to use it in epithelial and sensory-cell assays while separating channel engagement from downstream biology.

• Triacetin: A Mechanism-to-Assay Research Guide

  2026-08-24

  Triacetin, or glyceryl triacetate, connects metabolic perturbation with apoptosis and cell-cycle assays. This guide focuses on mechanism-to-endpoint alignment, translational boundaries, and how immuno-oncology research can sharpen experimental interpretation without overstating the evidence.

• N²-Alkyl-dG Lesions Drive R-Loop Accumulation

  2026-08-23

  The 2024 Nucleic Acids Research study shows that minor-groove N²-alkyl-dG lesions increase R-loop accumulation in chromatin and plasmid DNA, linking chemically modified guanine to transcriptional obstruction and genome instability. Its combination of fluorescence microscopy, R-loop sequencing, lesion-containing DNA models, and helicase genetics provides a mechanistic framework for studying how unrepaired alkylation damage alters transcription-associated DNA structures.

• Phebestin Targets Malaria Aminopeptidases

  2026-08-22

  The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its combination of stage-wide parasite activity, post-washout suppression, predicted binding to PfM1AAP and PfM17LAP, and efficacy in rodent malaria models supports aminopeptidases as promising targets while leaving important pharmacology and selectivity questions unresolved.

• Streptavidin-Cy3 for Mechanism-Driven NPC Assays

  2026-08-21

  Streptavidin-Cy3 enables bright, biotin-directed detection across immunohistochemistry, in situ hybridization, and cellular assays. This guide shows how to use the streptavidin cy3 conjugate to translate the NPM1/c-Myc/NDRG1 metastasis mechanism into better-controlled research workflows.

• CD28–ARS2 Splicing Rewires CD8+ T-Cell Metabolism

  2026-08-21

  The reference study identifies a CD28–ARS2 signaling axis that changes alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings separate this splicing-dependent metabolic program from canonical CD28–PI3K signaling and connect PKM isoform choice with interferon-γ production and antitumor effector activity.

• Adenosine triphosphate (ATP) for Cell Assays

  2026-08-20

  Learn how Adenosine triphosphate (ATP), SKU C6931, can support more interpretable cell viability, metabolism, and purinergic signaling workflows. This scenario-based guide covers compatibility, handling, protocol controls, data interpretation, and practical reagent selection.

• Panobinostat (LBH589): Applied HDAC Workflows

  2026-08-20

  Panobinostat (LBH589) supports practical studies of histone acetylation, apoptosis, and treatment resistance across leukemia, myeloma, and breast cancer models. This workflow-focused guide connects broad-spectrum HDAC inhibition with a new RNA polymerase II death-signaling framework while separating established evidence from testable experimental hypotheses.

• Bufalin Targets STK33 in Triple-Negative Breast Cancer

  2026-08-19

  A 2025 Advanced Science study identifies serine/threonine kinase 33 (STK33) as a binding target and degradation-sensitive vulnerability of Bufalin in triple-negative breast cancer. By combining chemoproteomic target discovery, biophysical binding assays, genetic perturbation, animal models, and patient-derived organoids, the work connects STK33 destabilization to suppression of tumor growth and metastasis.

443 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page